References
- Gralla R, Itri L, Pisko S. Antiemetic efficacy of high dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy induced nausea and vomiting. N Engl J Med 1981; 305: 905–909
- Carr BI, Bertrand M, Browning S. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double blind study. J Clin Oncol 1985; 3: 1127–1132
- Perrot J, Nahas G, Laville C, Dabay A. Substituted benzamides as antiemetics. Treatment of Cancer Chemotherapy Induced Nausea and Vomiting, D Poster. Masson, New York 1981; 195–207
- Hayes D, Evitokovic E, Golbey R. High dose CDDP: amelioration of renal toxicity by mannitol diuresis. Cancer 1977; 29: 1372–1381
- Nicaise C, Rozencweig M, Ortmans M. Etude en phase 1 de l'Alizapride chez des patients cancéreux traités au Cisplatine. Sem Hôp Paris 1983; 59: 2161–2165
- Pommateau E. Etude en double insu croisée Alizapride-placebo sur la prévention des nausées et des vomissements induits par la chimiotherapie antimitotique. Sem Hôp Paris 1982; 58: 363–366
- Roché H, Hyman G, Nahas G. Hypertension and intravenous anlidopaminergic drugs. N Engl J Med 1985; 312: 1125
- Sheridan C, Chandra P, Jacinto M, Greenwald ES. Transient hypertension after high doses of metoclopramide. N Engl J Med 1982; 307: 1346